Sonnet BioTherapeutics Holdings, Inc. (SONN)
Dec 2, 2025 - SONN was delisted (reason: merged into PURR)
1.260
-1.840 (-59.35%)
Inactive · Last trade price on Dec 2, 2025

SONN Balance Sheet

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Cash & Equivalents
0.320.152.273.0527.627.35
Cash & Short-Term Investments
0.320.152.273.0527.627.35
Cash Growth
-91.51%-93.43%-25.50%-88.95%275.81%1367.98%
Other Receivables
0.60.760.790.72--
Total Trade Receivables
0.60.760.790.72--
Other Current Assets
0.41.211.681.641.190.29
Total Current Assets
1.322.124.745.4128.817.64
Net Property, Plant & Equipment
0.080.140.230.30.180.27
Other Long-Term Assets
0.660.510.460.11-0.08
Total Assets
2.062.775.435.8328.997.99
Accounts Payable
3.752.182.24.753.782.06
Accrued Expenses
1.280.943.233.192.312.06
Short-Term Debt
---000.02
Current Portion of Leases
0.070.080.070.050.090.08
Unearned Revenue
--0.020.170.520.5
Total Current Liabilities
5.13.215.528.166.74.72
Long-Term Debt
-----0.12
Long-Term Leases
-0.050.130.20.030.13
Total Long-Term Liabilities
-0.050.130.20.030.25
Total Liabilities
5.13.265.668.376.734.97
Common Stock
000000
Additional Paid-in Capital
125.06117.2110.0288.8783.9539.72
Retained Earnings
-128.11-117.68-110.24-91.41-61.69-36.71
Total Common Shareholders' Equity
-3.05-0.49-0.23-2.5422.263.02
Shareholders' Equity
-3.05-0.49-0.23-2.5422.263.02
Total Liabilities & Equity
2.062.775.435.8328.997.99
Total Debt
0.070.130.20.260.130.35
Net Cash (Debt)
0.250.022.072.827.57
Net Cash Growth
1257.90%-99.10%-25.98%-89.83%292.99%-
Net Cash Per Share
0.090.0315.96113.312760.001830.03
Book Value
-3.05-0.49-0.23-2.5422.263.02
Book Value Per Share
-1.13-0.74-1.74-102.852234.39789.88
Tangible Book Value
-3.05-0.49-0.23-2.5422.263.02
Tangible Book Value Per Share
-1.13-0.74-1.74-102.852234.39789.88
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q